ATG16L1 rs2241880: What Your Genotype Means
The rs2241880 variant is a well-studied genetic polymorphism in the ATG16L1 gene, frequently referred to in scientific literature as the T300A mutation. It is strongly associated with an increased susceptibility to Crohn's disease and inflammatory bowel disease (IBD) by altering how cells perform autophagy.
What each genotype means
Typical adiponectin profile
This genotype represents the most common form of this variant in many populations. Research into the ADIPOQ gene suggests that variations in this region may influence circulating adiponectin levels, which play a role in insulin sensitivity and metabolic health. As this is a complex trait influenced by many genetic and lifestyle factors, this genotype does not indicate a specific health outcome.
This is the most common genotype observed in most global populations.
Varied metabolic risk profile
Carrying one copy of the G allele may be associated with subtle differences in how your body regulates adiponectin compared to those with the TT genotype. Studies on ADIPOQ variants indicate that these genetic differences can correlate with variations in insulin sensitivity and metabolic syndrome markers, though the effects are often small and influenced by diet and physical activity. Please discuss any concerns regarding your metabolic health with your healthcare provider.
This heterozygous genotype is found at moderate frequencies across diverse ancestral groups.
Potential metabolic sensitivity
Individuals with this genotype carry two copies of the G allele, which has been studied for its potential association with altered adiponectin levels and metabolic traits. While some research links this variant to differences in insulin sensitivity, these associations are often modest and depend heavily on environmental factors like lifestyle and overall body composition. This result is not a diagnosis and should be viewed as one small piece of your overall metabolic health profile.
This genotype is less common than the TT or TG combinations in most studied populations.
What is the rs2241880 Variant?
The genetic variant rs2241880 is a widely researched single nucleotide polymorphism (SNP) located within the ATG16L1 gene on chromosome 2. In scientific literature, this variant is frequently referred to as the T300A polymorphism. This name describes the specific biological change it causes: a substitution of the amino acid threonine (T) for alanine (A) at position 300 in the resulting protein. This substitution occurs when the DNA sequence contains a G allele instead of an A allele at this specific location. Because it directly alters the structure of the protein, rs2241880 is known as a missense variant. Researchers have extensively mapped this SNP due to its significant impact on gastrointestinal health and immune system function. While many genetic variants have no noticeable effect on human biology, the structural change introduced by the G allele at rs2241880 fundamentally modifies how the ATG16L1 protein operates within human cells, making it a primary focus in the study of autoimmune and inflammatory conditions.
The Role of the ATG16L1 Gene
To understand the impact of rs2241880, it is essential to understand the function of the ATG16L1 gene. This gene provides instructions for making a protein that is a critical component of a cellular process called autophagy. Autophagy is essentially the cell's internal recycling and waste disposal system. It allows cells to break down and clear out damaged components, cellular debris, and invading microorganisms, including harmful bacteria. In the human digestive tract, autophagy plays a vital role in maintaining the delicate balance between the immune system and the complex microbiome of the gut. When the ATG16L1 protein functions normally, it helps intestinal cells manage inflammation and defend against bacterial invasion. However, the T300A alteration caused by the rs2241880 G allele impairs this autophagic pathway. Consequently, cells become less efficient at clearing out intracellular pathogens and regulating inflammatory responses. This disruption in cellular housekeeping is believed to be a key mechanism that triggers abnormal immune responses in the gastrointestinal tract.
Association with Crohn's Disease
Extensive genome-wide association studies (GWAS) have established a strong, verifiable link between the rs2241880 G allele and an increased susceptibility to Crohn's disease, a type of inflammatory bowel disease (IBD). Research demonstrates that individuals carrying one or two copies of the G allele have a statistically higher risk of developing Crohn's disease compared to those with the A allele. The variant appears to account for a significant portion of the genetic risk conferred by the ATG16L1 locus. Interestingly, while the association with Crohn's disease is robust and replicated across multiple global populations, the evidence linking rs2241880 to ulcerative colitis—another major form of IBD—is much weaker and often conflicting. Some studies suggest a mild association, while others find no significant correlation at all. It is important to note that carrying the risk allele does not guarantee that a person will develop Crohn's disease. The condition is complex and multifactorial, requiring a combination of genetic predisposition, environmental triggers, and microbiome interactions to manifest.
Actionability and Limitations
While knowing your rs2241880 genotype can provide insight into your genetic predisposition for Crohn's disease, it is crucial to understand the limitations of this information. This genetic variant is a risk factor, not a diagnostic marker. Many individuals who carry the GG genotype never develop inflammatory bowel disease, just as some individuals with the AA genotype do develop it. Therefore, this information cannot be used to diagnose Crohn's disease or predict its onset with certainty. If you have a family history of IBD or are experiencing chronic gastrointestinal symptoms, you should discuss these concerns with a healthcare provider or a gastroenterologist. They can perform appropriate clinical evaluations, such as endoscopies or biomarker tests, which are necessary for a true diagnosis. From a lifestyle perspective, individuals with a higher genetic risk may choose to focus on general gut health through a balanced diet, stress management, and avoiding known IBD triggers like smoking, though these measures do not guarantee prevention.
How common is this variant?
The rs2241880 variant is a common polymorphism found globally, though the frequency of the risk-associated G allele varies by ancestry. It is particularly prevalent in populations of European descent, where it is a well-documented genetic contributor to Crohn's disease.
Frequently asked questions
What is Crohn's disease?
Crohn's disease is a chronic inflammatory bowel disease (IBD) characterized by inflammation of the digestive tract. It can cause symptoms such as severe abdominal pain, diarrhea, fatigue, and weight loss. The exact cause is unknown, but it involves a combination of genetics, immune system dysfunction, and environmental factors.
Does having the G allele mean I will definitely get Crohn's disease?
No, carrying the G allele only indicates a statistical increase in genetic susceptibility, not a certainty of disease. Many people with the G allele never develop Crohn's disease. Environmental triggers and other genetic factors play a massive role in whether the disease actually develops.
What is autophagy and why does it matter?
Autophagy is a natural cellular process that cleans out damaged components and destroys invading bacteria. In the gut, healthy autophagy helps prevent excessive inflammation. The rs2241880 variant impairs this process, which can lead to the chronic inflammation seen in Crohn's disease.
Is this variant linked to Ulcerative Colitis?
The evidence linking rs2241880 to ulcerative colitis is mixed and generally weak. While it is a strong risk factor for Crohn's disease, most major studies conclude that it does not significantly increase the risk for ulcerative colitis.
Can I change my genetic risk for Crohn's disease?
You cannot change your DNA, but genetics is only one part of the equation. Maintaining a healthy lifestyle, avoiding smoking, and managing stress can support overall gut health. Always consult a doctor for personalized advice on managing gastrointestinal risks.
Sources & further reading
Educational information only, last refreshed 9/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2241880?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADIPOQ
Promoter variant (-11391G>A) in the ADIPOQ gene associated with circulating adiponectin levels.
Common regulatory polymorphism in the ADIPOQ gene associated with circulating adiponectin levels.
This SNP is associated with circulating adiponectin levels and metabolic syndrome risk.
This SNP is studied for its role in adiponectin levels and metabolic response to diet.
A candidate SNP in the adiponectin gene investigated for its potential association with human longevity and aging phenotypes.
A variant in the ADIPOQ gene linked to inflammatory regulation and insulin sensitivity in the context of dietary intake.